טוען...
Silymarin use and liver diease progression in the HALT-C trial
BACKGROUND: Silymarin is the most commonly used herbal product for chronic liver disease, yet whether silymarin protects against liver disease progression remains unclear. AIM: To assess the effects of silymarin use on subsequent liver disease progression in 1049 patients of the Hepatitis C Antivira...
שמור ב:
| Main Authors: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3490214/ https://ncbi.nlm.nih.gov/pubmed/21083592 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2036.2010.04503.x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|